SCHEMBL22490901

SCHEMBL22490901

C=CCO[C@@H]1[C@@H](O)[C@H](O)[C@@H](COC(=O)c2ccc(OCc3ccccc3)cc2)O[C@@H]1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 1/20 0.44
CHRNA5 P30532 1/20 0.44
CHRNA7 P36544 1/20 0.44
CHRNA4 P43681 1/20 0.44
PARP10 Q53GL7 1/20 0.42
NR4A1 P22736 1/20 0.41
NR4A2 P43354 1/20 0.41
NR4A3 Q92570 1/20 0.41
MAOB P27338 1/20 0.40
ADRB2 P07550 1/20 0.39
ADRB1 P08588 1/20 0.39
ADRB3 P13945 1/20 0.39
SRD5A2 P31213 1/20 0.39
PLA2G4B P0C869 1/20 0.38
HIF1A Q16665 1/20 0.37
KDM4E B2RXH2 2/20 0.37
NPC1 O15118 1/20 0.37
ALDH1A1 P00352 1/20 0.37
RAB9A P51151 1/20 0.37
EGFR P00533 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21112978 0.88 SMN1; SMN2 (0.41) PARP10MAOBKDM4EALDH1A1RAB9A
SCHEMBL23488254 0.88 CHRNB2 (0.45) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490879 0.87 CHRNB2 (0.48) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490912 0.85 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490932 0.85 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490872 0.85 CHRNB2 (0.50) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490902 0.84 CHRNB2 (0.52) CHRNB2CHRNA5CHRNA7CHRNA4PARP10
SCHEMBL22490911 0.81 PARP10 (0.40) PARP10NR4A1NR4A2NR4A3MAOB
SCHEMBL21112929 0.80 MEN1 (0.40) PARP10ADRB2ADRB1ADRB3KDM4E
SCHEMBL23488283 0.79 MAOB (0.45) PARP10NR4A1NR4A2NR4A3MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed
EP-3717463-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN Sanofi (FR) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 CHRNB2 3085/4885CHRNA5 3785/4885CHRNA7 4025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.